Clinical usefulness of lipid ratios to identify men and women with metabolic syndrome: a cross-sectional study

[1] Ford ES(2008)Metabolic syndrome and incident diabetes Diabetes Care 31 1898-1904

[2] Li C(2011)Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14120 hypertensive patients of ASCOT-BPLA: comparisons of their relative predictability using a novel approach Diabetic Medicine 28 941-947

[3] Sattar N(2006)Metabolic syndrome and risk of cardiovascular disease: a meta-analysis Am J Med 119 812-819

[4] Gupta AK(2007)Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies JACC 49 403-414

[5] Prieto-Merino D(2006)The metabolic syndrome in developing countries Diabetes Voice 51 15-17

[6] Dahlof B(2004)Increasing prevalence of the metabolic syndrome among US adults Diabetes Care 27 2444-2449

[7] Sever PS(1999)Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabetes Medicine 16 442-443

[8] Poulter NR(2002)Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report Circulation 106 3143-1645

[9] Galassi A(2009)Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 1640-19

[10] Reynolds K(2012)Perceptions of Canadian primary care physicians towards cardiovascular risk assessment and lipid management Can J Cardiology 28 14-428

[1] Ford ES(2008)Metabolic syndrome and incident diabetes Diabetes Care 31 1898-1904

[2] Li C(2011)Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14120 hypertensive patients of ASCOT-BPLA: comparisons of their relative predictability using a novel approach Diabetic Medicine 28 941-947

[3] Sattar N(2006)Metabolic syndrome and risk of cardiovascular disease: a meta-analysis Am J Med 119 812-819

[4] Gupta AK(2007)Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies JACC 49 403-414

[5] Prieto-Merino D(2006)The metabolic syndrome in developing countries Diabetes Voice 51 15-17

[6] Dahlof B(2004)Increasing prevalence of the metabolic syndrome among US adults Diabetes Care 27 2444-2449

[7] Sever PS(1999)Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabetes Medicine 16 442-443

[8] Poulter NR(2002)Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report Circulation 106 3143-1645

[9] Galassi A(2009)Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 1640-19

[10] Reynolds K(2012)Perceptions of Canadian primary care physicians towards cardiovascular risk assessment and lipid management Can J Cardiology 28 14-428